How can metabolomics accelerate translation from models to patients?
In this Benelux Metabolomics Seminar on “Metabolomics for clinical applications” three excellent speakers highlight how cutting-edge
metabolomics approaches are advancing clinical research and precision medicine.
📢 “Metabolomics for clinical applications.”
⏰ Thursday 29 January, 15-16:30 CET
👉 [https://lnkd.in/e3Rw55_S]
For more information and abstract check the flyer here
Programme
• Victoria Pozo Garcia (Sanquin, NL) – Using LC-MS metabolomics to benchmark and improve iPSC-derived cell models for drug discovery and clinical applications
• Esther Zaal (Utrecht University, NL) – How metabolic adaptation drives therapy resistance in cancer, revealed through metabolomics and fluxomics
• Yiming Peng-Winkler (VIB / KU Leuven, BE) – Mapping spatial cancer metabolism with MALDI mass spectrometry imaging to uncover novel metabolic vulnerabilities
Together, these talks demonstrate how metabolomics is helping to:
✔️ Improve the maturity and functionality of cell models
✔️ Identify metabolic drivers of drug resistance
✔️ Reveal spatial metabolic heterogeneity invisible to bulk analyses
A great example of how metabolomics is moving from discovery to real clinical impact.